Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 159

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy

Wen, X-F, Yang, G, Mao, W, Thornton, A, Liu, J, Bast, R C, Le, X-F · 2006 · Oncogene

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1209685

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • VEGF-Trap: A VEGF blocker with potent antitumor effects

    Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398299 · Cited by 1,691 · cited 2×

    “Combination therapy with trastuzumab and a therapeutic molecule targeting VEGF and/or its receptors, such as the recombinant humanized monoclonal anti-VEGF antibody bevacizumab (Pegram and Reese, 2002; Miller et al., 2005) and VEGF-TRAP (Holash et al., 2002), may prove active against HER2-overexpressing breast cancers.”
    Background
  • Herceptin acts as an anti-angiogenic cocktail

    Izumi, Y., Xu, L., di Tomaso, E., Fukumura, D., & Jain, R. K. (2002) · Nature · doi:10.1038/416279b · Cited by 623

  • Signal transduction and oncogenesis by ErbB/HER receptors

    Marmor, M. D., Skaria, K. B., & Yarden, Y. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.06.002 · Cited by 389 · cited 1×

    “The human epidermal growth factor receptor 2 (HER2, also known as ErbB-2 or c-neu) plays a critical role in epidermal growth factor receptor (EGFR) family signaling (Zhang et al., 2003; Holbro and Hynes, 2004; Marmor et al., 2004).”
    Background

Cited by

See all 159

Metadata

Authors
Wen, X.-F., Yang, G., Mao, W., Thornton, A., Liu, J., Bast, R. C., & Le, X.-F.
Venue
Oncogene
Published
2006-05-22
Volume
25
Issue
52
Pages
6986-6996
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W1988104771
Cited by
159
References
3
FWCI
7.44
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.